IQVIA (IQV) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, IQVIA Holdings (IQV) reported revenue of $4.1 billion, up 5.2% over the same period last year. EPS came in at $3.00, compared to $2.84 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $4.07 billion, representing a surprise of +0.86%. The company delivered an EPS surprise of +1.35%, with the consensus EPS estimate being $2.96.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how IQVIA performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Backlog: $32.40 billion compared to the $32.49 billion average estimate based on two analysts.Revenues- Technology & Analytics Solutions: $1.63 billion compared to the $1.66 billion average estimate based on six analysts. The reported number represents a change of +5% year over year.Revenues- Research & Development Solution: $2.26 billion versus $2.23 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.5% change.Revenues- Contract Sales & Medical Solutions: $209 million compared to the $180.27 million average estimate based on six analysts. The reported number represents a change of +16.1% year over year.Segment Profit- Technology & Analytics Solution: $370 million compared to the $412.55 million average estimate based on two analysts.Segment Profit- Contract Sales & Medical Solutions: $13 million versus $0.84 million estimated by two analysts on average.Segment Profit- Research & Development Solutions: $496 million versus $495.9 million estimated by two analysts on average.View all Key Company Metrics for IQVIA here>>>Shares of IQVIA have returned +20.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IQVIA Holdings Inc. (IQV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks